Connotation of serum levels of vitamin D3 and LL-37 with urinary tract infection in type 2 diabetic patients
Open Access
- 21 January 2026
- journal article
- Published by Elsevier in Clinical Epidemiology and Global Health
- Vol. 38
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Predictive Factors for Urinary Tract Infections in Patients with Type 2 DiabetesJournal of Clinical Medicine, 2024
- Patterns of Lipid Abnormalities in Obesity: A Comparative Analysis in Normoglycemic and Prediabetic Obese IndividualsJournal of Personalized Medicine, 2024
- Recurrent Urinary tract infections and type 2 diabetes mellitus: a systematic review predominantly in womenFrontiers in Urology, 2023
- Lipidomics Profiling of Metformin-Induced Changes in Obesity and Type 2 Diabetes Mellitus: Insights and Biomarker PotentialPharmaceuticals, 2023
- Assessment of Lipid Profile among Sudanese patients with Type 2 Diabetes MellitusAL-Kindy College Medical Journal, 2022
- HIF-1 mediated activation of antimicrobial peptide LL-37 in type 2 diabetic patientsJournal of Molecular Medicine, 2021
- Vitamin D and Cathelicidin (LL-37) Status in Patients with Type 2 Diabetes and Staphylococcus aureus Nasal CarriageThe Review of Diabetic Studies, 2021
- Causal Relationship between Obesity and Vitamin D Status: Bi-Directional Mendelian Randomization Analysis of Multiple CohortsPLOS Medicine, 2013
- Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice GuidelineThe Journal of Clinical Endocrinology & Metabolism, 2011